National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria

<p>Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal blood disorder caused by somatic mutation of the phosphatidylinositol<br />glycan complementation group A gene (PIG-A) in a hematopoietic stem cell. PNH is characterized by chronic intravascular hemolysis, bone marrow...

Full description

Bibliographic Details
Main Authors: A. D. Kulagin, I. A. Lisukov, V. V. Ptushkin, Ye. R. Shilova, N. V. Tsvetaeva, Ye. A. Mikhailova
Format: Article
Language:Russian
Published: ABV-press 2014-09-01
Series:Онкогематология
Subjects:
Online Access:http://oncohematology.abvpress.ru/index.php/ongm/article/view/111
_version_ 1811173575723319296
author A. D. Kulagin
I. A. Lisukov
V. V. Ptushkin
Ye. R. Shilova
N. V. Tsvetaeva
Ye. A. Mikhailova
author_facet A. D. Kulagin
I. A. Lisukov
V. V. Ptushkin
Ye. R. Shilova
N. V. Tsvetaeva
Ye. A. Mikhailova
author_sort A. D. Kulagin
collection DOAJ
description <p>Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal blood disorder caused by somatic mutation of the phosphatidylinositol<br />glycan complementation group A gene (PIG-A) in a hematopoietic stem cell. PNH is characterized by chronic intravascular hemolysis, bone marrow failure, thrombosis, renal dysfunction and other severe clinical syndromes. These clinical guidelines include definition, classification, methods and diagnostic criteria of PNH, indications for screening, optimal treatment including targeted therapy with eculizumab, bone marrow transplantation and symptomatic therapy.</p>
first_indexed 2024-04-10T17:50:17Z
format Article
id doaj.art-f349757c62a74939ab2532630746408a
institution Directory Open Access Journal
issn 1818-8346
language Russian
last_indexed 2024-04-10T17:50:17Z
publishDate 2014-09-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj.art-f349757c62a74939ab2532630746408a2023-02-02T22:27:58ZrusABV-pressОнкогематология1818-83462014-09-01922028126National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuriaA. D. Kulagin0I. A. Lisukov1V. V. Ptushkin2Ye. R. Shilova3N. V. Tsvetaeva4Ye. A. Mikhailova5First I.P. Pavlov State Medical University of St.‑Petersburg, Ministry of Health of RussiaI.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia, Saint PetersburgFederal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, MoscowRussian Research Institute of Hematology and Transfusiology, Russian Federal Biomedical Agency, Saint PetersburgHematology Research Center, Ministry of Health of Russia, MoscowHematology Research Center, Ministry of Health of Russia, Moscow<p>Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal blood disorder caused by somatic mutation of the phosphatidylinositol<br />glycan complementation group A gene (PIG-A) in a hematopoietic stem cell. PNH is characterized by chronic intravascular hemolysis, bone marrow failure, thrombosis, renal dysfunction and other severe clinical syndromes. These clinical guidelines include definition, classification, methods and diagnostic criteria of PNH, indications for screening, optimal treatment including targeted therapy with eculizumab, bone marrow transplantation and symptomatic therapy.</p>http://oncohematology.abvpress.ru/index.php/ongm/article/view/111paroxysmal nocturnal hemoglobinuriaaplastic anemiacomplementhemolysisflow cytometrythrombosisbone marrow transplantationeculizumab
spellingShingle A. D. Kulagin
I. A. Lisukov
V. V. Ptushkin
Ye. R. Shilova
N. V. Tsvetaeva
Ye. A. Mikhailova
National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
Онкогематология
paroxysmal nocturnal hemoglobinuria
aplastic anemia
complement
hemolysis
flow cytometry
thrombosis
bone marrow transplantation
eculizumab
title National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
title_full National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
title_fullStr National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
title_full_unstemmed National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
title_short National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
title_sort national clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
topic paroxysmal nocturnal hemoglobinuria
aplastic anemia
complement
hemolysis
flow cytometry
thrombosis
bone marrow transplantation
eculizumab
url http://oncohematology.abvpress.ru/index.php/ongm/article/view/111
work_keys_str_mv AT adkulagin nationalclinicalguidelinesforthediagnosisandtreatmentofparoxysmalnocturnalhemoglobinuria
AT ialisukov nationalclinicalguidelinesforthediagnosisandtreatmentofparoxysmalnocturnalhemoglobinuria
AT vvptushkin nationalclinicalguidelinesforthediagnosisandtreatmentofparoxysmalnocturnalhemoglobinuria
AT yershilova nationalclinicalguidelinesforthediagnosisandtreatmentofparoxysmalnocturnalhemoglobinuria
AT nvtsvetaeva nationalclinicalguidelinesforthediagnosisandtreatmentofparoxysmalnocturnalhemoglobinuria
AT yeamikhailova nationalclinicalguidelinesforthediagnosisandtreatmentofparoxysmalnocturnalhemoglobinuria